Attovia Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops biotherapeutics for immune-mediated diseases in the United States. The company provides ATTOBODY, a biparatopic biologics platform designed to deliver improved treatments. The company's products include ATTO-1310, a...
13 insider purchases on record · latest filing 2026-08-28.
Insiders have also filed 88 sale transactions at ATTO.